what does this mean for IMU and the combo trial?
I guess that would depend on what the results show ?
KEYTRUDA® (pembrolizumab) comes off patent in 2028 so I guess Merck are looking at a number of options ....
..... there are many KEYTRUDA® trials and combo trials ( https://clinicaltrials.gov/search?intr=KEYTRUDA® ) happening now outside of the IMU combo trial so I guess we will jut have to wait and see if anything in IMU's combo trial piqued Merk's interest but it looks like they have a number of options outside of IMU ?
GLTAH
Media Thread, page-13942
-
- There are more pages in this discussion • 723 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add IMU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
5.9¢ |
Change
0.005(9.26%) |
Mkt cap ! $433.6M | |||
| Open | High | Low | Value | Volume |
| 5.5¢ | 5.9¢ | 5.4¢ | $1.489M | 25.99M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 35252 | 5.9¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 6.0¢ | 1753430 | 24 |
View Market Depth
| Last trade - 16.10pm 12/07/2024 (20 minute delay) ? |
| IMU (ASX) Chart |